clofibrate has been researched along with Coronary Disease in 259 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of clofibrate treatment have been monitored in a double-blind cross-over study conducted in 16 male patients with coronary heart disease." | 9.04 | The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease. ( Enger, SC; Johnsen, V; Laws, EA; Samuelsen, A, 1977) |
| "The effect of clofibrate on the same subjects in similar test conditions were used as a control to verify the alleged beneficial effects from garlic and onion on alimentary hyperlipemia in normals and in cases with ischemic heart disease." | 7.66 | Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia. ( Arora, RC; Arora, S, 1981) |
| "Male and female, arteriosclerotic and non-arteriosclerotic rats were treated with the anti-lipemic agent, clofibrate, for 8 days and then subjected to an acute myocardial infarction by injecting them with two large doses of isoproterenol spaced 24 hours apart." | 7.66 | Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. ( Greenberg, BP; Wexler, BC, 1978) |
| "Ankle systolic pressure measurements in 67 patients with intermittent claudication treated with Clofibrate for an average period of 11 months and 32 untreated patients suggest that 1) patients with a raised initial plasma fibrinogen concentration have more severe disease than those with low initial plasma fibrinogen concentration and 2) the response to treatment with Clofibrate is significantly better in those with a raised plasma fibrinogen concentration." | 7.65 | Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate. ( Dormandy, JA; Postlethwaite, JC, 1975) |
| "The effects of clofibrate treatment have been monitored in a double-blind cross-over study conducted in 16 male patients with coronary heart disease." | 5.04 | The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease. ( Enger, SC; Johnsen, V; Laws, EA; Samuelsen, A, 1977) |
| "Results of recent clinical trials on secondary prevention of ischemic heart disease indicate that judicious, long-term administration of adrenergic beta blockers and platelet-active drugs such as aspirin and Persantine (dipyridamole) would seem to yield protection against mortality associated with acute myocardial infarction, including sudden death." | 3.67 | Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases. ( Borhani, NO, 1985) |
| "The effect of clofibrate on the same subjects in similar test conditions were used as a control to verify the alleged beneficial effects from garlic and onion on alimentary hyperlipemia in normals and in cases with ischemic heart disease." | 3.66 | Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia. ( Arora, RC; Arora, S, 1981) |
| "Male and female, arteriosclerotic and non-arteriosclerotic rats were treated with the anti-lipemic agent, clofibrate, for 8 days and then subjected to an acute myocardial infarction by injecting them with two large doses of isoproterenol spaced 24 hours apart." | 3.66 | Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. ( Greenberg, BP; Wexler, BC, 1978) |
| "Ankle systolic pressure measurements in 67 patients with intermittent claudication treated with Clofibrate for an average period of 11 months and 32 untreated patients suggest that 1) patients with a raised initial plasma fibrinogen concentration have more severe disease than those with low initial plasma fibrinogen concentration and 2) the response to treatment with Clofibrate is significantly better in those with a raised plasma fibrinogen concentration." | 3.65 | Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate. ( Dormandy, JA; Postlethwaite, JC, 1975) |
| " Patients receiving clofibrate and both estrogen dosage groups had the highest incidence of cholecystitis or cholelithiasis." | 2.64 | Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project. ( , 1977) |
| "Several forms of dyslipidemia are associated with premature coronary artery disease (CAD) and other vascular disease." | 2.39 | Hyperlipidemia: perspectives in diagnosis and treatment. ( Gotto, AM; Yeshurun, D, 1995) |
| "Fibric acid derivatives may interact with other drugs and the interactions can be of clinical relevance." | 2.39 | Drug interactions with fibric acids. ( Dujovne, CA; Lozada, A, 1994) |
| "The pathogenesis of arteriosclerosis is unknown." | 1.26 | [Lipid lowering treatment and regression of arteriosclerosis (author's transl)]. ( Greten, H; Klose, G, 1980) |
| "Bezafibrate is a potent lipid-lowering agent of the new generation." | 1.26 | Clinical experience with bezafibrate. ( Hausmann, L; Kaffarnik, H; Mühlfellner, G; Mühlfellner, O; Schneider, J; Schubotz, R, 1980) |
| " The dosage reduction from the usual clofibrate dose of 14 g/week avoided toxicity and corrected the abnormalities in serum triglyceride and high density lipoprotein cholesterol levels to or toward normal." | 1.26 | Chronic clofibrate therapy in maintenance hemodialysis patients. ( Brunzell, JD; Goldberg, AB; Haas, LB; Sherrard, DJ, 1980) |
| "Type V hyperlipemia is not very common." | 1.26 | [Type V hyperlipemia. 54 cases (author's transl)]. ( Beaumont, V; Buxtorf, JC; Jacotot, B; Schlesinger, M, 1979) |
| "Hyperlipemia is one of several risk factors for premature ischemic vascular disease." | 1.26 | A pathophysiologic approach to managing hyperlipemia. ( Hazzard, WR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 239 (92.28) | 18.7374 |
| 1990's | 12 (4.63) | 18.2507 |
| 2000's | 6 (2.32) | 29.6817 |
| 2010's | 2 (0.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, D | 1 |
| Liu, B | 1 |
| Tao, W | 1 |
| Hao, Z | 1 |
| Liu, M | 1 |
| Chiba, Y | 1 |
| Oliver, M | 2 |
| Abramson, J | 1 |
| OLIVER, MF | 14 |
| ROBERTS, SD | 1 |
| HAYES, D | 1 |
| PANTRIDGE, JF | 1 |
| SUZMAN, MM | 1 |
| BERSOHN, I | 1 |
| BARNETT, AJ | 1 |
| CARSON, V | 1 |
| DE MEIRING, PV | 1 |
| OGSTON, CM | 1 |
| OGSTON, D | 1 |
| MCANDREW, GM | 1 |
| PEAK, HJ | 1 |
| MITCHELL, AS | 1 |
| JOSE, AD | 1 |
| Fujioka, T | 1 |
| Ueno, T | 1 |
| Matsumoto, T | 1 |
| Watanabe, H | 1 |
| Williams, GE | 1 |
| Sirtori, CR | 1 |
| Marshall, AJ | 1 |
| Heller, RF | 1 |
| Green, KG | 2 |
| Moore, KH | 1 |
| Bonema, JD | 1 |
| Solomon, FJ | 1 |
| Colman, RW | 1 |
| Stamler, J | 3 |
| Epstein, LH | 1 |
| Nash, DT | 1 |
| Buchwald, H | 1 |
| Fitch, L | 1 |
| Moore, RB | 1 |
| Klose, G | 1 |
| Greten, H | 1 |
| Schade, RW | 1 |
| Rose, G | 1 |
| Temple, NJ | 1 |
| Verstraete, M | 5 |
| Tan, MH | 1 |
| Reimers, HJ | 2 |
| Misera, R | 1 |
| Schneider, W | 1 |
| Loogen, F | 1 |
| Cristol, R | 1 |
| Lamm, G | 2 |
| Vessby, B | 1 |
| Lithell, H | 2 |
| Boberg, J | 1 |
| Turpie, AG | 2 |
| Ware, JH | 1 |
| Akhmeteli, MA | 1 |
| Sailer, D | 1 |
| Kolb, S | 1 |
| Kazakov, IuM | 1 |
| Fabbrocini, V | 1 |
| Schubotz, R | 1 |
| Schneider, J | 1 |
| Hausmann, L | 1 |
| Mühlfellner, G | 1 |
| Mühlfellner, O | 1 |
| Kaffarnik, H | 1 |
| Arora, RC | 1 |
| Arora, S | 1 |
| Heady, JA | 3 |
| Lucis, OJ | 1 |
| Hedstrand, H | 1 |
| Gustafsson, IB | 1 |
| Hood, B | 1 |
| Sznajderman, M | 1 |
| Keys, A | 1 |
| McMichael, J | 2 |
| Sherrard, DJ | 1 |
| Goldberg, AB | 1 |
| Haas, LB | 1 |
| Brunzell, JD | 1 |
| Bierman, EL | 1 |
| Rosenhamer, G | 2 |
| Carlson, LA | 3 |
| Boss, N | 1 |
| Wietelmann, H | 1 |
| Bierner, M | 1 |
| Rudolph, W | 1 |
| Schlepper, M | 1 |
| Koenig-Erich, S | 1 |
| Ruhenstroth-Bauer, G | 1 |
| Schettler, G | 1 |
| Guerrera, G | 1 |
| Melina, D | 1 |
| Croveri, G | 1 |
| Gould, AL | 1 |
| Rossouw, JE | 1 |
| Santanello, NC | 1 |
| Heyse, JF | 1 |
| Furberg, CD | 1 |
| Yeshurun, D | 1 |
| Gotto, AM | 2 |
| Lozada, A | 1 |
| Dujovne, CA | 1 |
| Smith, GD | 1 |
| Egger, M | 1 |
| Welborn, TA | 1 |
| Holme, I | 1 |
| Schiel, R | 1 |
| Bambauer, R | 1 |
| Müller, UA | 1 |
| Fruchart, JC | 1 |
| Brewer, HB | 1 |
| Leitersdorf, E | 1 |
| Pritzker, LB | 1 |
| Haffner, SM | 1 |
| Tada, N | 1 |
| Klungel, OH | 1 |
| Heckbert, SR | 1 |
| de Boer, A | 1 |
| Leufkens, HG | 1 |
| Sullivan, SD | 1 |
| Fishman, PA | 1 |
| Veenstra, DL | 1 |
| Psaty, BM | 1 |
| Haft, JI | 1 |
| Chakrabarti, R | 1 |
| Meade, TW | 1 |
| Cooper, J | 1 |
| Geizerova, H | 4 |
| Thompson, GR | 1 |
| Lowenthal, R | 1 |
| Myant, NB | 1 |
| Glusa, E | 1 |
| Anisimov, VE | 1 |
| Goliakov, VN | 1 |
| Semavin, IE | 1 |
| Dinçol, K | 1 |
| Ozkan, E | 1 |
| Ekmekçi, A | 1 |
| MacGregor, GA | 1 |
| Downie, CC | 1 |
| Olsson, AG | 1 |
| Rider, AK | 1 |
| Kanaide, H | 1 |
| Nakamura, M | 1 |
| Krivoruchenko, IV | 1 |
| Nikul'cheva, NG | 1 |
| Borhani, NO | 2 |
| Dilman, VM | 1 |
| Gustafson, A | 2 |
| Manninen, V | 1 |
| Mälkönen, M | 1 |
| Tuomilehto, J | 1 |
| Schlesinger, M | 1 |
| Jacotot, B | 1 |
| Beaumont, V | 1 |
| Buxtorf, JC | 1 |
| Hart, A | 1 |
| Steele, P | 2 |
| Rainwater, J | 1 |
| Vogel, R | 1 |
| Genton, E | 5 |
| Grundy, SM | 1 |
| Enger, SC | 1 |
| Johnsen, V | 1 |
| Samuelsen, A | 1 |
| Laws, EA | 1 |
| Komarov, FI | 1 |
| Liusov, VA | 1 |
| Bokarev, IN | 1 |
| Caceres, CA | 1 |
| Enslein, K | 1 |
| Weiss, HJ | 1 |
| Hirsh, J | 4 |
| Vaisrub, S | 2 |
| de Gennes, JL | 1 |
| Gryglik, J | 1 |
| Dettori, AG | 1 |
| Pini, M | 1 |
| Quintavalla, R | 1 |
| Fejfar, Z | 3 |
| Gantmacher, ML | 1 |
| Pick, R | 1 |
| Glick, G | 1 |
| Scott, HW | 1 |
| Parenti, M | 1 |
| Pasquali, R | 1 |
| Bianchi, V | 1 |
| Barillari, C | 1 |
| Vezzadini, P | 1 |
| Mehta, J | 1 |
| Mehta, P | 1 |
| Strandberg, K | 1 |
| Gyarfas, I | 1 |
| Morris, JN | 1 |
| Green, K | 1 |
| Strasser, T | 1 |
| Hartmann, G | 1 |
| Micheli, H | 1 |
| Mordasini, R | 1 |
| Noseda, G | 1 |
| Stähelin, HB | 1 |
| Viikinkoski, P | 1 |
| Balaguer Vintro, I | 1 |
| Bjerkelund, C | 1 |
| Miettinen, M | 1 |
| Turpeinen, O | 1 |
| Karvonen, MJ | 1 |
| Kritchevsky, D | 1 |
| Kukes, VG | 2 |
| Senik, EA | 1 |
| Gneushev, ET | 1 |
| Utlinskaia, MG | 1 |
| Nasonov, AS | 1 |
| Jarmolych, J | 1 |
| Daoud, AS | 1 |
| Fritz, KE | 2 |
| Augustyn, JM | 2 |
| Singh, JK | 1 |
| Kim, DN | 1 |
| Daoud, AD | 1 |
| Jarmolych, H | 1 |
| Lee, KT | 1 |
| Wexler, BC | 1 |
| Greenberg, BP | 1 |
| Huttunen, J | 1 |
| Harker, LA | 2 |
| Gent, M | 2 |
| Ahrens, EH | 1 |
| Howard, AN | 1 |
| Zakharov, VN | 1 |
| Deriagina, GP | 1 |
| Mustard, JF | 1 |
| Packham, MA | 1 |
| Kinlough-Rathbone, RL | 1 |
| Eaton, RP | 1 |
| Schade, DS | 1 |
| Lueker, R | 1 |
| Hazzard, WR | 1 |
| Cohn, K | 1 |
| Sakai, FJ | 1 |
| Langston, MF | 1 |
| Scott, PJ | 1 |
| Erikssen, J | 1 |
| Parsons, WB | 1 |
| Postlethwaite, JC | 1 |
| Dormandy, JA | 1 |
| Tierney, E | 1 |
| Battock, D | 1 |
| Gans, DJ | 1 |
| Santrůcek, M | 1 |
| Hejl, Z | 2 |
| Grafnetter, D | 2 |
| Mjos, OD | 1 |
| Miller, NE | 1 |
| Riemersma, RA | 1 |
| Valiensi, M | 1 |
| Riboli, E | 1 |
| Lombardi, M | 1 |
| Itakura, H | 1 |
| Hunninghake, DB | 1 |
| Rywik, S | 1 |
| Heady, A | 1 |
| Miettinen, TA | 2 |
| Huttunen, JK | 1 |
| Naukkarinen, V | 1 |
| Strandberg, T | 1 |
| Vanhanen, H | 1 |
| Islami, Y | 1 |
| Ribeiro, LG | 1 |
| Prasad, MR | 1 |
| Clement, R | 1 |
| Jones, R | 1 |
| Engelman, RM | 1 |
| Otani, H | 1 |
| Das, DK | 1 |
| Naito, HK | 1 |
| Jones, PH | 1 |
| Scott, LW | 1 |
| Levy, RI | 3 |
| Fenwick, GR | 1 |
| Hanley, AB | 1 |
| Gerö, S | 1 |
| Menotti, A | 1 |
| Puddu, V | 1 |
| Caruzzo, C | 1 |
| Wilson, DE | 1 |
| Lees, RS | 1 |
| Haviar, V | 2 |
| Riecanský, L | 1 |
| Kusá, O | 2 |
| Luknárová, O | 2 |
| Albeaux-Fernet, M | 1 |
| Gelinet, M | 1 |
| Deribreux, J | 1 |
| Rufli, T | 1 |
| Stähelin, H | 1 |
| Rifking, BM | 1 |
| Appelbaum, JJ | 1 |
| Amundsen, MA | 1 |
| Perkin, DK | 1 |
| Rifkind, BM | 1 |
| Saheta, NP | 1 |
| Fitzgerald, JD | 1 |
| Ditschuneit, H | 1 |
| Neugebauer, A | 1 |
| Trenckmann, H | 1 |
| Duck, HJ | 1 |
| Fleischmann, HJ | 1 |
| Schauer, J | 1 |
| Nolan, J | 1 |
| St John-Brooks, WH | 1 |
| Frenk, E | 1 |
| Walker, AE | 1 |
| Edwards, IR | 1 |
| Michajlik, A | 1 |
| Krikler, DM | 1 |
| Begg, TB | 1 |
| Dewar, HA | 5 |
| Jepson, EM | 1 |
| Ruzyllo, E | 1 |
| Szostak, WB | 1 |
| Cybulska, B | 1 |
| Oye, I | 1 |
| Wolfram, G | 1 |
| Bavina, MV | 1 |
| Perova, NV | 1 |
| Lobova, NM | 1 |
| Koropova, GI | 1 |
| Metelitsa, VI | 1 |
| Ostrovskaia-Tsarfis, TP | 1 |
| Kokurina, EV | 1 |
| Sapozhnikov, II | 1 |
| Aleksandrov, AA | 1 |
| Gillam, PM | 1 |
| Gormsen, J | 1 |
| Mertz, DP | 1 |
| Schwoerer, P | 1 |
| Babucke, G | 1 |
| Naess, K | 1 |
| Riecanský, I | 1 |
| Fowler, PB | 1 |
| Kudchodkar, BJ | 1 |
| Sodhi, HS | 1 |
| Horlick, L | 1 |
| Krasno, LR | 1 |
| Kidera, GJ | 1 |
| Dorr, AE | 1 |
| Nikkilä, E | 1 |
| Ylikahri, R | 1 |
| Kähönen, M | 1 |
| Kannel, WB | 1 |
| Garcia, MJ | 1 |
| McNamara, PM | 1 |
| Pearson, G | 1 |
| Cotton, RC | 1 |
| Fearnley, GR | 1 |
| Sivkov, II | 1 |
| Kirichenko, LL | 1 |
| Fedosova, NS | 1 |
| Ishmaeva, KA | 1 |
| Davignon, J | 1 |
| Aubry, F | 1 |
| Noël, C | 1 |
| Lapierre, Y | 1 |
| Lafortune, M | 1 |
| Huth, K | 1 |
| Schoenborn, W | 1 |
| Fuhrmann, W | 1 |
| Page, IH | 1 |
| Lewis, LA | 1 |
| Melloni, GF | 1 |
| Fassini, G | 1 |
| Smith, AF | 1 |
| Macfie, WG | 1 |
| el-Mehairy, MM | 1 |
| Attia, O | 1 |
| Nabih, AE | 1 |
| Nassar, I | 1 |
| Ibrahim, WN | 1 |
| Vanĕcek, R | 1 |
| Margolis, S | 1 |
| Bianchi, EM | 1 |
| Foresti, A | 1 |
| Casertano, F | 1 |
| De Ponti, C | 1 |
| Riva, D | 1 |
| Sharland, DE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000490] | Phase 3 | 0 participants | Interventional | 1973-06-30 | Completed | ||
| [NCT00000482] | Phase 3 | 0 participants | Interventional | 1965-04-30 | Completed | ||
| EFFECT OF PLANT STEROLS ON THE LIPID PROFILE OF PATIENTS WITH HYPERCHOLESTEROLAEMIA. RANDOMISED, EXPERIMENTAL STUDY[NCT01406106] | 182 participants (Actual) | Interventional | 2010-01-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
54 reviews available for clofibrate and Coronary Disease
| Article | Year |
|---|---|
Fibrates for secondary prevention of cardiovascular disease and stroke.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Bezafibrate; Cardiovascular Diseases; Caus | 2015 |
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronar | 2004 |
Strategy of reducing coronary risk and the use of drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Cerebrovascular Disorders; Cholesterol; Clofibra | 1984 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; C | 1981 |
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
Topics: Cholesterol; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperl | 1984 |
The direct effects of compliance on health outcome.
Topics: Alcoholism; Chlorpromazine; Chorionic Gonadotropin; Clofibrate; Coronary Disease; Disulfiram; Drug T | 1984 |
[Hyperlipoproteinemia type II].
Topics: Adolescent; Adult; Cecum; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary Di | 1980 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprof | 1980 |
HDL-cholesterol: the negative risk factor for coronary heart disease.
Topics: Adult; Age Factors; Alcoholism; Child; Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Clofibra | 1980 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
The cardiovascular disease programme of WHO/EURO. A critical review of its first 12 years.
Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Clofibrate; Coronary Disease; Double-Blind | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Hea | 1981 |
[Prevention of cardiovascular diseases].
Topics: Adult; Arteriosclerosis; Blood Pressure; Cholesterol; Clofibrate; Coronary Disease; Humans; Hyperten | 1982 |
Cholesterol reduction yields clinical benefit. A new look at old data.
Topics: Cholesterol; Cholesterol, Dietary; Clofibrate; Coronary Disease; Dextrothyroxine; Estrogens; Gemfibr | 1995 |
Hyperlipidemia: perspectives in diagnosis and treatment.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Fat-Re | 1995 |
Drug interactions with fibric acids.
Topics: Anticoagulants; Bezafibrate; Clofibrate; Clofibric Acid; Contraceptives, Oral; Coronary Disease; Dru | 1994 |
Dyslipidaemia in non-insulin dependent diabetes: the need for a clinical intervention trial.
Topics: Cholesterol, HDL; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diabetes Mellitus, Type 2; | 1994 |
Relationship between total mortality and cholesterol reduction as found by meta-regression analysis of randomized cholesterol-lowering trials.
Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Coronary Disease; Humans; Myocardial Infarction; | 1996 |
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group.
Topics: Animals; Cholesterol, LDL; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hydroxymethylg | 1998 |
Do lipid lowering drugs reduce the risk of coronary heart disease?
Topics: Angiography; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Artery Disease | 1998 |
[Overviews of fibrate].
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL | 2001 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Co | 1979 |
[Current studies on antilipemic agents].
Topics: Animals; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hypolipidemic Agen | 1975 |
The position of long-term stimulation of the endogenous fibrinolytic system: present achievements and clinical perspectives.
Topics: Adrenocorticotropic Hormone; Anabolic Agents; Androgens; Clofibrate; Coronary Disease; Deamino Argin | 1975 |
Primary prevention of coronary heart disease: a critique.
Topics: Adult; Blood Pressure; Cholesterol; Clofibrate; Coronary Disease; Dextrothyroxine; Dietary Carbohydr | 1977 |
Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Topics: Cholesterol; Chylomicrons; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Hypolipidemic Agen | 1975 |
Treatment of hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Cole | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
Cardiac thromboembolism: evidence for role of platelets and value of platelet suppressant therapy.
Topics: Aspirin; Blood Platelets; Cell Survival; Clofibrate; Coronary Disease; Heart Diseases; Heart Valve D | 1978 |
[Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease].
Topics: Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Platelet Aggregation | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Hea | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Topics: Alcohol Drinking; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hyper | 1975 |
The management of hyperlipidemia: whether, rather than how.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dietary Fats; Drug Evaluation; | 1976 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
[Clofibrate in coronary diseases].
Topics: Clofibrate; Coronary Disease; Humans | 1975 |
Drug treatment of dyslipoproteinemia.
Topics: Bile Acids and Salts; Clofibrate; Coronary Disease; Drug Therapy, Combination; Gemfibrozil; Humans; | 1990 |
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up | 1988 |
Reducing cardiac deaths with hypolipidemic drugs.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfi | 1987 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibr | 1986 |
The genus Allium--Part 3.
Topics: Allium; Animals; Arteriosclerosis; Asthma; Bacteria; Blood Glucose; Blood Protein Electrophoresis; C | 1985 |
Review of primary prevention trials of coronary heart disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topi | 1985 |
Lipid lowering drugs and hyperlipidaemia.
Topics: Biological Transport; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; | 1973 |
Does hypolipidemic therapy prevent coronary heart disease?
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Female; Humans; Hyperlip | 1974 |
Iatrogenic cardiovascular disease (an aspect of preventive cardiology).
Topics: Abnormalities, Drug-Induced; Analgesics; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antidepressi | 1968 |
Experimental approaches to the prophylaxis and treatment of ischaemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Angina Pectoris; Animals; Biphenyl Compou | 1971 |
Therapeutics XIX. Lipid lowering agents.
Topics: Animals; Arteriosclerosis; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Coronary Disea | 1972 |
[Drug prevention of coronary disease].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cholestyramine Resin; Clofibrate; Coronary Diseas | 1972 |
[Hiperlipidemia as a risk factor in coronary artery disease].
Topics: Age Factors; Blood Protein Disorders; Cholesterol; Clofibrate; Coronary Disease; Diet Therapy; Human | 1973 |
Therapy of lipid disorders.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet Therapy; Drug | 1973 |
67 trials available for clofibrate and Coronary Disease
| Article | Year |
|---|---|
W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Double-Blind Method; Follow-Up | 1980 |
WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Humans; Male | 1984 |
Interpretation of clofibrate trial.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Double-Blind Method; Humans; Male; Random Al | 1984 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; D | 1983 |
The direct effects of compliance on health outcome.
Topics: Alcoholism; Chlorpromazine; Chorionic Gonadotropin; Clofibrate; Coronary Disease; Disulfiram; Drug T | 1984 |
Overview of randomized clinical trials of lipid intervention for atherosclerotic cardiovascular disease.
Topics: Arteriosclerosis; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Fatty Acids, U | 1982 |
Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Human | 1980 |
Influence of treatment adherence in the coronary drug project.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Patient Compliance | 1981 |
[Platelets and coronary artery disease (CAD) (author's transl)].
Topics: Animals; Aspirin; Autopsy; Blood Platelets; Cardiomyopathies; Cell Wall; Clinical Trials as Topic; C | 1980 |
The cardiovascular disease programme of WHO/EURO. A critical review of its first 12 years.
Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Clofibrate; Coronary Disease; Double-Blind | 1981 |
Will serum lipid lowering treatment reduce the incidence of coronary heart disease?
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diet; Female; Humans; Hy | 1981 |
Comparison of medical and surgical management of coronary artery disease: methodologic issues.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Artery Bypass; Coronary Disease; Data Collection; Fem | 1982 |
A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate: some statistical aspects.
Topics: Adult; Cholesterol; Clofibrate; Coronary Disease; Humans; Male; Middle Aged; Patient Dropouts | 1981 |
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, | 1995 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Co | 1979 |
Letter: Clofibrate in prevention of ischaemic heart-disease.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Fibrinolysis; Humans; Platelet Adhesiveness; | 1975 |
Letter: Clofibrate and gallstones.
Topics: Adult; Cholelithiasis; Clofibrate; Coronary Disease; Humans; Male; Middle Aged | 1975 |
Clofibrate: a final verdict?
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Drug Evaluation; Humans; | 1978 |
Clofibrate.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hyperlipidemias; Ne | 1979 |
Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hypercholesterol | 1979 |
Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project.
Topics: Adult; Age Factors; Anticholesteremic Agents; Body Height; Body Weight; Cholecystitis; Cholelithiasi | 1977 |
The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Clofibrate; Coronary Disease; Fibrinogen; Gluc | 1977 |
The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrothyroxine; Double- | 1977 |
[Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
Topics: Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary D | 1978 |
Coronary drug project.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Nicotinic Acids | 1978 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical T | 1978 |
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
Topics: Adult; Cardiovascular Diseases; Cholelithiasis; Cholesterol; Clinical Trials as Topic; Clofibrate; C | 1978 |
Cholesterol, coronaries, clofibrate and death.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Death, Sudden; Humans; H | 1978 |
Cooperative clofibrate trial.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Humans; Male | 1979 |
[Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
Topics: Adult; Arteriosclerosis; Cholelithiasis; Clinical Trials as Topic; Clofibrate; Coronary Disease; Eur | 1979 |
The clofibrate trial--the lipid hypothesis retested.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Double-Blind Method; Humans; Hy | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Double-Blind Method; Hum | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Topics: Alcohol Drinking; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hyper | 1975 |
The management of hyperlipidemia: whether, rather than how.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dietary Fats; Drug Evaluation; | 1976 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise | 1975 |
Clofibrate and niacin in coronary heart disease.
Topics: Adult; Arterial Occlusive Diseases; Cerebrovascular Disorders; Cholesterol; Clinical Trials as Topic | 1975 |
Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man.
Topics: Arteriosclerosis; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Artery Bypass; Coronar | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Lipid lowering drugs and coronary heart disease.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diet; Humans; Hypolipidemic Age | 1975 |
[Is hypolipemic treatment effective as a preventive measure?].
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Clofibrat | 1989 |
Long-term use of probucol in the multifactorial primary prevention of vascular disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cerebrovascular Disorders; Cholesterol, HDL; C | 1986 |
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up | 1988 |
Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.
Topics: Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Female; Humans; Lipids; L | 1988 |
Prevention of coronary heart disease--propaganda, promises, problems, and prospects.
Topics: Adult; Arteriosclerosis; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diet; | 1986 |
Strategy, yield and risks of controlling plasma lipids in the primary prevention of coronary heart disease.
Topics: Adult; Arteriosclerosis; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diet; | 1985 |
Primary prevention of coronary heart disease by lowering lipids: results and implications.
Topics: Cholesterol, LDL; Clinical Trials as Topic; Clofibrate; Coronary Artery Bypass; Coronary Disease; Di | 1985 |
Review of primary prevention trials of coronary heart disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topi | 1985 |
The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
Topics: Adult; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrothyro | 1970 |
The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
Topics: Adult; Cholesterol; Clofibrate; Coronary Disease; Dextrothyroxine; Electrocardiography; Estrogens, C | 1972 |
The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.
Topics: Adult; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrothyro | 1973 |
Does hypolipidemic therapy prevent coronary heart disease?
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Female; Humans; Hyperlip | 1974 |
Clofibrate and coronary heart disease.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Coronary Circulation; Coronary Disease; Evaluatio | 1972 |
Trial of clofibrate.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Female; Humans; Male; Middle Aged | 1972 |
The coronary drug project. Design, methods, and baseline results.
Topics: Adult; Alkaline Phosphatase; Anticholesteremic Agents; Bilirubin; Blood Glucose; Blood Pressure; Blo | 1973 |
Clofibrate in the treatment and prevention of ischaemic heart disease: recent trials.
Topics: Angina Pectoris; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Lipopr | 1972 |
A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Coronary Disease; Europe; Humans; Hyperlipidemias; Inte | 1973 |
General therapeutic and prophylactic problems in the treatment of atherosclerosis.
Topics: Aged; Arteriosclerosis; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diet Therapy; Dietar | 1972 |
Long-term therapy of ischaemic heart disease.
Topics: Angina Pectoris; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Death, Sudden; | 1972 |
Clofibrate for prevention of myocardial infarction.
Topics: Angina Pectoris; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hypercholesterolemi | 1973 |
Clofibrate in ischaemic heart disease.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Myocardial Infarction | 1971 |
Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.
Topics: Adult; Angina Pectoris; Anticoagulants; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary | 1971 |
Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; E | 1971 |
Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; D | 1971 |
Clofibrate in coronary heart disease. Effect on morbidity and mortality.
Topics: Adult; Age Factors; Angina Pectoris; Blood Pressure; Cholesterol; Clofibrate; Coronary Disease; Huma | 1972 |
Clofibrate, serum enzymes, and muscle pain.
Topics: Adult; Alkaline Phosphatase; Anticholesteremic Agents; Aspartate Aminotransferases; Cholesterol; Clo | 1970 |
150 other studies available for clofibrate and Coronary Disease
| Article | Year |
|---|---|
Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates.
Topics: Anticholesteremic Agents; Biostatistics; Clofibrate; Coronary Disease; Humans; Outcome Assessment, H | 2009 |
The clofibrate saga: a retrospective commentary.
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Disease; Gallstones; Humans | 2012 |
Comments on the MRC/BHF Heart Protection Study.
Topics: Adult; Antihypertensive Agents; Cholesterol; Clofibrate; Coronary Disease; Cost-Benefit Analysis; Di | 2003 |
Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
Topics: Androsterone; Anticoagulants; Butyrates; Clofibrate; Coronary Disease; Hypercholesterolemia; Hyperli | 1963 |
ATROMID-S AND ATROMID.
Topics: Androsterone; Arteriosclerosis; Butyrates; Cerebrovascular Disorders; Clofibrate; Coronary Disease; | 1964 |
"ATROMID" IN ATHEROSCLEROSIS.
Topics: Androsterone; Angina Pectoris; Arteriosclerosis Obliterans; Atherosclerosis; Blood Chemical Analysis | 1964 |
THE EFFECT OF ATROMID AND ATROMID-S ON PLASMA FIBRINOGEN AND PLASMINOGEN LEVELS.
Topics: Androsterone; Anticholesteremic Agents; Biomedical Research; Butyrates; Clofibrate; Coronary Disease | 1965 |
A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.
Topics: Androsterone; Anticholesteremic Agents; Butyrates; Clofibrate; Coronary Disease; Drug Therapy; Elect | 1965 |
The clofibrate problem.
Topics: Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Male | 1980 |
The clofibrate problem: a different viewpoint.
Topics: Animals; Biotransformation; Clofibrate; Coronary Disease; Humans; Neoplasms; Phenoxyacetates; Rats | 1980 |
Mechanism of action of clofibrate.
Topics: Clofibrate; Coronary Disease; Humans | 1981 |
Coronary heart disease, cancer, lipoproteins, and the effects of clofibrate: is enzyme induction a common link and are lipoproteins red herrings?
Topics: Carcinogens; Cholesterol; Cholesterol, HDL; Clofibrate; Coronary Disease; Enzyme Induction; Humans; | 1981 |
Long-chain acyl-CoA and acylcarnitine hydrolase activities in normal and ischemic rabbit heart.
Topics: Animals; Carboxylic Ester Hydrolases; Clofibrate; Coronary Disease; Epoxy Compounds; Fatty Acids; Ma | 1984 |
The role of platelets in the genesis of ischemia.
Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Blood Platelets; Cholesterol; Clofibrate; Coronary | 1982 |
Hyperlipidemia: reducing the chances of cardiovascular disease.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemia | 1984 |
[Lipid lowering treatment and regression of arteriosclerosis (author's transl)].
Topics: Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; C | 1980 |
Strategy of prevention: lessons from cardiovascular disease.
Topics: Adult; Aged; Cholesterol; Cholesterol, Dietary; Clofibrate; Contraceptives, Oral; Coronary Disease; | 1981 |
Coronary heart disease--dietary lipids or refined carbohydrates?
Topics: Clofibrate; Coronary Disease; Dietary Carbohydrates; Dietary Fats; Epidemiologic Methods; Feeding Be | 1983 |
Serious adverse effects with clofibrate.
Topics: Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Male; United Kingdom | 1980 |
Lipid lowering and ischaemic heart disease.
Topics: Adult; Cholesterol; Clofibrate; Coronary Disease; Dietary Fats; Humans; Lipids; Lipoproteins; Male; | 1981 |
Clofibrate in the management of hyperlipidaemia.
Topics: Clofibrate; Coronary Disease; Humans; Hyperlipidemias | 1982 |
[Treatment of coronary heart disease with diet and lipid-reducing agents].
Topics: Adolescent; Adult; Child; Cholestyramine Resin; Clofibrate; Clofibric Acid; Colestipol; Coronary Dis | 1982 |
[Blood viscosity and hematocrit indices in arteriosclerosis].
Topics: Adolescent; Adult; Arteriosclerosis; Blood Viscosity; Clofibrate; Coronary Disease; Hematocrit; Huma | 1981 |
[Study of clofibrate. The opinion of Prof. D. Kritchevsky].
Topics: Adult; Arteriosclerosis; Cholelithiasis; Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hype | 1980 |
Clinical experience with bezafibrate.
Topics: Bezafibrate; Blood Glucose; Body Weight; Cholesterol; Clofibrate; Clofibric Acid; Coronary Disease; | 1980 |
Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia.
Topics: Adult; Arteriosclerosis; Clofibrate; Coronary Disease; Fibrinogen; Garlic; Humans; Hyperlipidemias; | 1981 |
Present status of clofibrate in Canada.
Topics: Canada; Clofibrate; Coronary Disease; Humans; Lipoproteins, VLDL | 1981 |
Significant and persistent reduction of serum lipids in asymptomatic men.
Topics: Cholesterol; Clofibrate; Coronary Disease; Follow-Up Studies; Humans; Hyperlipidemias; Lipids; Male; | 1981 |
[Clofibrate--facts and controversies].
Topics: Cholesterol; Clofibrate; Coronary Disease; Humans | 1980 |
Coronary heart disease, serum cholesterol, and the diet.
Topics: Cholesterol; Clofibrate; Coronary Disease; Dietary Fats; Humans; Prospective Studies; Smoking | 1980 |
Diet and coronary disease.
Topics: Cholesterol; Clofibrate; Coronary Disease; Dietary Fats; Fats, Unsaturated; Humans | 1980 |
Chronic clofibrate therapy in maintenance hemodialysis patients.
Topics: Adult; Arteriosclerosis; Cholesterol; Clofibrate; Coronary Disease; Humans; Kidney Failure, Chronic; | 1980 |
Triglycerides and coronary heart disease.
Topics: Clofibrate; Coronary Disease; Humans; Middle Aged; Triglycerides | 1980 |
Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease.
Topics: Clofibrate; Coronary Disease; Coronary Vessels; Drug Therapy, Combination; Female; Humans; Lipids; M | 1980 |
Hyperlipidaemia advances and retreats.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Lipoprotei | 1980 |
Red blood cell aggregation in men with coronary artery disease.
Topics: Adult; Clofibrate; Coronary Disease; Erythrocyte Aggregation; Female; Humans; Male; Middle Aged; Sta | 1980 |
[Undesirable effects of hypolipemic drugs].
Topics: Adult; Arrhythmias, Cardiac; Avitaminosis; Biliary Tract Diseases; Cholestyramine Resin; Clofibrate; | 1980 |
[Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
Topics: Aged; Clofibrate; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Py | 1980 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Human | 1980 |
Clinical trials and clinical practice.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Drug Utilization; Humans | 1993 |
Secondary prevention of coronary heart disease: the role of fibric acids.
Topics: Anticholesteremic Agents; Clofibrate; Coronary Disease; Humans; Pravastatin | 2000 |
Lipid-lowering drug use and cardiovascular events after myocardial infarction.
Topics: Cholesterol; Clofibrate; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Humans; | 2002 |
Plasma exchange in the management of homozygous familial hypercholesterolaemia.
Topics: Adult; Aortic Diseases; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Di | 1975 |
[The importance of platelet function for the detection of thrombosis susceptibliity].
Topics: Blood Platelet Disorders; Blood Platelets; Clofibrate; Contraceptives, Oral; Coronary Disease; Densi | 1975 |
[Effect of various preparations on hyperuricemia in coronary arteriosclerosis].
Topics: Aged; Anticholesteremic Agents; Clofibrate; Coronary Disease; Drug Therapy, Combination; Heparinoids | 1977 |
Clofibrate in prevention of ischaemic heart-disease.
Topics: Adult; Blood Coagulation; Clofibrate; Coronary Disease; Humans; Male | 1975 |
Clofibrate.
Topics: Bile Acids and Salts; Clofibrate; Colonic Neoplasms; Coronary Disease; Drug Evaluation; Humans; Hype | 1978 |
Clofibrate and malignancy.
Topics: Adenocarcinoma; Adult; Clofibrate; Coronary Disease; Humans; Intestinal Neoplasms; Jejunum; Male; Mi | 1979 |
[Clofibrate prevention study by WHO. Results and consequences].
Topics: Clofibrate; Coronary Disease; Humans; World Health Organization | 1979 |
Fats and atheroma: an inquest.
Topics: Animals; Arteriosclerosis; Cholesterol; Clofibrate; Coronary Disease; Dietary Fats; Fats, Unsaturate | 1979 |
Should hyperlipoproteinemia be treated in patients with coronary artery disease?
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Body Weight; Cholestyramine Resin; Clofibrate; Coronary D | 1975 |
[Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
Topics: Cholesterol; Chylomicrons; Clofibrate; Coronary Disease; Drug Evaluation; Female; Humans; Hyperlipid | 1976 |
Ageing, metabolic immunodepression and carcinogenesis.
Topics: Adult; Aged; Aging; Cell Transformation, Neoplastic; Cholesterol; Clofibrate; Coronary Disease; Diab | 1978 |
Treating lipid disorders.
Topics: Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hypercholesterolemia; Hyperlipidemias; Hypoli | 1979 |
[Type V hyperlipemia. 54 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Alcoholism; Blood Protein Electrophoresis; Child; Child, Preschool; Cholest | 1979 |
The value of clofibrate.
Topics: Clofibrate; Coronary Disease; Humans; Hyperlipidemias | 1978 |
Clofibrate and the prevention of ischaemic heart disease.
Topics: Adult; Clofibrate; Coronary Disease; Humans; Male; Middle Aged | 1979 |
Platelet-suppressant therapy in patients with coronary artery disease.
Topics: Adult; Blood Platelets; Cell Survival; Clofibrate; Coronary Artery Bypass; Coronary Disease; Death, | 1978 |
Effects of propranolol, minoxidil, and clofibrate on cholesterol-induced atherosclerosis in stumptail macaques (Macaca arctoides).
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Clofibrate; Coronary Disease; Coronary Vessels; Diet, | 1977 |
Ileal bypass in the control of hyperlipidemia and atherosclerosis.
Topics: Adult; Animals; Aorta; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary | 1978 |
[The clofibrate-dipyridamole combination in the treatment of athero-arteriosclerotic vasculopathy].
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Drug E | 1979 |
Status of antiplatelet drugs in coronary heart disease.
Topics: Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Male; Models, Biologic | 1979 |
Corrigendum.
Topics: Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hyperlipidemias | 1979 |
[Decision of the Department of Drugs of the National Board of Health and Welfare: indications for the use of clofibrate will be limited].
Topics: Cholesterol; Clofibrate; Coronary Disease; Drug Evaluation; Humans; Sweden; World Health Organizatio | 1979 |
[Primary prevention of ischemic heart disease using clofibrate. Cooperative epidemiological study].
Topics: Adult; Clofibrate; Coronary Disease; Czechoslovakia; Humans; Hungary; International Cooperation; Mal | 1979 |
[Clofibrate--helpful or harmful?].
Topics: Adult; Cholecystitis; Cholesterol; Clofibrate; Coronary Disease; Germany, West; Humans; Hyperlipidem | 1979 |
[Clofibrate--overreaction?].
Topics: Clofibrate; Coronary Disease; Humans; Hyperlipidemias | 1979 |
[Primary prevention of ischemic cardiopathy with clofibrate].
Topics: Clofibrate; Coronary Disease; Humans | 1979 |
[Clofibrate in the primary prevention of coronary disease].
Topics: Clofibrate; Coronary Disease; Humans; Hypercholesterolemia | 1979 |
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate.
Topics: Clofibrate; Coronary Disease; Dietary Fats; Fats, Unsaturated; Humans | 1979 |
[The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini].
Topics: Arteriosclerosis; Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Hyperlipidemias; Myoca | 1979 |
[Study of pharmacodynamics and pharmacokinetics of clofibrate for the purpose of selection of optimal course of treatment of ischemic heart disease].
Topics: Adult; Biological Availability; Clofibrate; Coronary Disease; Dose-Response Relationship, Drug; Fema | 1979 |
Panic and clofibrate.
Topics: Anticholesteremic Agents; Clofibrate; Coronary Disease; Drug Evaluation; Germany, West; Humans; Legi | 1979 |
Morphological effects of moderate diet and clofibrate on swine atherosclerosis.
Topics: Animals; Cholesterol, Dietary; Clofibrate; Coronary Disease; Coronary Vessels; Diet, Atherogenic; Ma | 1978 |
Biochemical effects of moderate diet and clofibrate on swine atherosclerosis.
Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Clofibrate; Collagen | 1978 |
Antiplatelet agents in coronary disease: are they of prophylactic value?
Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrin | 1978 |
Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Blood Urea Nitrogen; Clof | 1978 |
Clofibrate and the primary prevention of ischaemic heart disease.
Topics: Adult; Cholesterol; Clofibrate; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction | 1978 |
Cholesterol, coronaries, clofibrate and death.
Topics: Aged; Cholesterol; Clofibrate; Coronary Disease; Humans; Male; Middle Aged; Mortality | 1979 |
[Clofibrate--more harm than good?].
Topics: Clofibrate; Coronary Disease; Death, Sudden; Humans | 1979 |
[Hypolipidemic efficacy of clofibrate preparations (atromid C, atromidine, mixleron) in coronary atherosclerosis with different types of hyperlipoproteinemia].
Topics: Aged; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Middle Aged | 1977 |
[Effect of miscleron on various indicators of blood coagulation in ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation; Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Male; | 1977 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; | 1977 |
Clofibrate-induced changes in glucagon and insulin secretion in patients with angiographically documented coronary artery disease.
Topics: Adult; Arginine; Clofibrate; Coronary Disease; Female; Glucagon; Humans; Insulin; Insulin Secretion; | 1977 |
A pathophysiologic approach to managing hyperlipemia.
Topics: Adult; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Lipid Me | 1976 |
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coro | 1976 |
Hyperlipidemia: to treat or not to treat.
Topics: Cerebrovascular Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyper | 1975 |
Editorial: After a coronary.
Topics: Angina Pectoris; Cholesterol; Clofibrate; Coronary Disease; Humans; Myocardial Infarction; Nicotinic | 1975 |
Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.
Topics: Ankle; Blood Flow Velocity; Blood Pressure; Blood Pressure Determination; Blood Viscosity; Clofibrat | 1975 |
The investigation and treatment of hyperlipidaemia in general practice.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Reducing; Family Pract | 1975 |
Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
Topics: Adult; Blood Platelets; Cell Survival; Cholesterol; Clofibrate; Coronary Disease; Humans; Hyperlipid | 1975 |
Letter: Coronary drug project.
Topics: Clofibrate; Coronary Disease; Humans; Nicotinic Acids; Semantics | 1975 |
[Experiences of 15 years in the screening of ischaemic heart diseases and arterial hypertension].
Topics: Cholesterol; Clofibrate; Coronary Disease; Czechoslovakia; Humans; Hypertension; Male; Middle Aged; | 1975 |
Effects of p-chlorophenoxyisobutyrate on myocardial free fatty acid extraction, ventricular blood flow, and epicardial ST-segment elevation during coronary occlusion in dogs.
Topics: Animals; Blood Pressure; Clofibrate; Coronary Circulation; Coronary Disease; Dogs; Electrophysiology | 1976 |
[Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Topics: Adult; Aged; Arteriosclerosis; Carbamates; Clofibrate; Coronary Disease; Drug Combinations; Female; | 1976 |
[Treatment of hyperlipidemia].
Topics: Blood Component Removal; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dieta | 1992 |
Should trials carry a health warning?
Topics: Cause of Death; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Humans; I | 1991 |
Blood pressure, cigarette smoking and heart attack in the WHO co-operative trial of clofibrate.
Topics: Bezafibrate; Clofibrate; Coronary Disease; Fibrinogen; Humans; Hypertension; Male; Smoking; World He | 1989 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; | 1985 |
Effect of ischemia and reperfusion of the myocardium on in vitro beta-oxidation of fatty acids.
Topics: Animals; Catalase; Clofibrate; Coronary Disease; Creatine Kinase; Fatty Acids; Heart Arrest, Induced | 1988 |
[Therapy and prevention of arteriosclerosis].
Topics: Adult; Aged; Animals; Anticoagulants; Aorta; Arteriosclerosis; Blood Coagulation Disorders; Blood Co | 1971 |
[Short-term pilot study of the feasibility of multifactor reduction of coronary risk].
Topics: Adult; Arteriosclerosis; Clofibrate; Clopamide; Coronary Disease; Diet Therapy; Dietary Fats; Ergolo | 1973 |
[Anti-hyperlipemic therapy in the secondary prevention of coronary heart disease. Long-term study].
Topics: Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Male; Niacinamide; Nicotinic Acids; P | 1974 |
Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
Topics: Adolescent; Adult; Angina Pectoris; Body Weight; Cholesterol; Clofibrate; Coronary Disease; Female; | 1972 |
Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
Topics: Adult; Aged; Cholesterol; Clofibrate; Coronary Disease; Fatty Acids; Female; Glycerol; Heparin; Huma | 1972 |
[Sheehan's disease followed by severe arterial hypertension with right renal artery stenosis. Discussion of the role of hypopituitarism in atherogenesis].
Topics: Adrenal Cortex Hormones; Adult; Androgens; Arteriosclerosis; Clofibrate; Coronary Disease; Female; H | 1973 |
[Xanthomatosis as a symptom of hyperlipidemic metabolic disorders. Relationship of the morphological picture to the lipid of three patients].
Topics: Adult; Arterial Occlusive Diseases; Blood Protein Electrophoresis; Cholestyramine Resin; Chylomicron | 1972 |
Altering lipid patterns in adult males.
Topics: Adult; Aged; Blood Protein Electrophoresis; Cholesterol; Chylomicrons; Clofibrate; Coronary Disease; | 1974 |
The influence of drugs affecting lipids on atherosclerosis.
Topics: Adult; Arteriosclerosis; Blood Protein Disorders; Clofibrate; Coronary Disease; Diabetes Complicatio | 1974 |
[Diagnosis and treatment of risk factors in chronic ischemic heart disease].
Topics: Adult; Age Factors; Arteriosclerosis; Cholestyramine Resin; Chronic Disease; Clofibrate; Coronary Di | 1974 |
Clofibrate and heart disease.
Topics: Angina Pectoris; Clofibrate; Coronary Disease; Death, Sudden; Humans | 1972 |
Atromid-S in eye disease.
Topics: Blood Coagulation; Cholesterol; Clofibrate; Coronary Disease; Diabetic Retinopathy; Eye Diseases; Fa | 1974 |
Do fats matter.
Topics: Arteries; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Coronary Di | 1972 |
The influence of clofibrate on glucose tolerance in patients with coronary heart disease.
Topics: Aged; Arteriosclerosis; Clofibrate; Coronary Disease; Female; Glucose; Glucose Tolerance Test; Human | 1972 |
Ischemic heart disease: a secondary prevention trial using clofibrate (Atromid-S).
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Clofibrate; Coronary Disease; Death, Sudden; Electroencep | 1972 |
[Clofibrate and ischemic heart disease].
Topics: Clofibrate; Coronary Disease; Humans; Hyperlipidemias | 1973 |
Reversibility of lipid deposition.
Topics: Arteriosclerosis; Cholesterol; Clofibrate; Cornea; Coronary Disease; Coronary Vessels; Evaluation St | 1973 |
[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
Topics: Adult; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Electropho | 1973 |
[Value of epidemiological studies in validating primary and secondary prevention of ischemic heart disease].
Topics: Clofibrate; Coronary Disease; Coumarins; Exercise Therapy; Humans; Male; Middle Aged; Moscow; Prospe | 1973 |
Editorial: The value of clofibrate in coronary heart disease.
Topics: Angina Pectoris; Clofibrate; Coronary Disease; Death, Sudden; Evaluation Studies as Topic; Humans; L | 1974 |
Fibrinolytic activity and haemagglutination inhibition immunoassays.
Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fi | 1970 |
Trial of clofibrate.
Topics: Aged; Clofibrate; Coronary Disease; Humans; Male; Middle Aged | 1972 |
Trial of clofibrate.
Topics: Angina Pectoris; Clofibrate; Coronary Disease; Fatty Acids, Nonesterified; Humans | 1972 |
Cardio-vascular disease and public health.
Topics: Australia; Cardiovascular Diseases; Clofibrate; Coronary Disease; Humans; Prognosis; Public Health; | 1972 |
[Classification of hyperlipoproteinaemia in primary gout].
Topics: Adult; Aged; Arteriosclerosis; Blood Protein Disorders; Body Weight; Carbohydrate Metabolism; Clofib | 1972 |
Confusion with clofibrate.
Topics: Angina Pectoris; Cholesterol; Clofibrate; Coronary Disease; Humans; Male | 1972 |
[Atromidin in ischemic heart disease. A brief preliminary communication].
Topics: Clofibrate; Coronary Disease; Humans | 1972 |
[Treatment of hyperlipidemia in patients with ischemic heart disease].
Topics: Clofibrate; Coronary Disease; Female; Heparin; Humans; Hyperlipidemias; Lipid Metabolism; Male; Midd | 1972 |
[Use of Clofibrate Spofa in the prevention of ischemic heart disease].
Topics: Clofibrate; Coronary Disease; Evaluation Studies as Topic; Humans; World Health Organization | 1972 |
Thyrotropin immunoassay.
Topics: Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Thyrotropin | 1972 |
Lack of degradation of dietary and endogenous sterols in gastrointestinal tract of man.
Topics: Adult; Angina Pectoris; Cholesterol; Clofibrate; Coronary Disease; Diet; Digestive System; Feces; Fe | 1972 |
Clofibrate and coronary arteries.
Topics: Clofibrate; Coronary Disease; Humans; Lipids; Male | 1972 |
[Clofibrate and coronary disease].
Topics: Adult; Cholesterol; Clofibrate; Coronary Disease; Female; Humans; Male; Middle Aged | 1972 |
[The clinical and biochemical aspects of clofibrate].
Topics: Animals; Arteriosclerosis; Chemical Phenomena; Chemistry; Clofibrate; Coronary Disease; Diabetic Ret | 1972 |
Serum lipid precursors of coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholesterol; Cholestyramine Res | 1971 |
[Results of a 5-year study of the action of clofibrate in the treatment of ischemic cardiopathy].
Topics: Adult; Cholesterol; Clofibrate; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infa | 1971 |
[Action of Atromid-S on thrombogenic factors].
Topics: Animals; Anticholesteremic Agents; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; | 1971 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation | 1971 |
[Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
Topics: Aged; Blood Coagulation; Clofibrate; Coronary Disease; Electrocardiography; Female; Fibrinolytic Age | 1971 |
Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
Topics: Adult; Blood Glucose; Blood Protein Disorders; Cholesterol; Clofibrate; Coronary Disease; Fasting; F | 1971 |
[Clinical picture of the type-3-hyperlipoproteinemia].
Topics: Adult; Aged; Arteriosclerosis; Blood Protein Disorders; Clofibrate; Coronary Disease; Diet Therapy; | 1971 |
A long-time study of the blood lipids of two students of atherosclerosis.
Topics: Age Factors; Aged; Arteriosclerosis; Body Weight; Cholesterol; Clofibrate; Coronary Disease; Diet; D | 1969 |
[Evaluation of the action of clofibrate on the blood lipid pattern as a parameter of rehabilitation of the cardiopathic patient].
Topics: Adult; Aged; Clofibrate; Coronary Disease; Disability Evaluation; Heart Block; Heart Defects, Congen | 1969 |
Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
Topics: Adult; Aged; Anticholesteremic Agents; Biopsy; Blood Proteins; Child; Cholesterol; Clofibrate; Coron | 1970 |
Prevention of ischaemic heart disease. Possibilities and problems.
Topics: Adult; Age Factors; Aged; Cholesterol; Clofibrate; Coronary Disease; Czechoslovakia; Diet; Female; H | 1970 |
Treatment of hyperlipidemia.
Topics: Anticholesteremic Agents; Clofibrate; Coronary Disease; Diet Therapy; Dietary Carbohydrates; Dietary | 1970 |
[Effect of long-term administration of a combination of clofibrate and a mucopolysaccharide extract complex].
Topics: Adult; Anticholesteremic Agents; Cholesterol; Clofibrate; Coronary Disease; Humans | 1970 |
Five-year trial of clofibrate in ischaemic heart disease.
Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Coronary Disease | 1971 |
Current attempts at prevention of ischaemic heart disease.
Topics: Adult; Anticholesteremic Agents; Clofibrate; Coronary Disease; Diet Therapy; England; Humans; Hyperc | 1971 |
Management of excess serum lipid.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Ileum; Neo | 1971 |